UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature reviews. Immunology, ISSN 1474-1733, 07/2009, Volume 9, Issue 7, pp. 491 - 502
Life Sciences & Biomedicine | Immunology | Science & Technology | B-Cell Maturation Antigen - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins - immunology | Humans | Toll-Like Receptors - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - metabolism | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins - metabolism | Transmembrane Activator and CAML Interactor Protein - metabolism | Signal Transduction - immunology | Lymphocyte Activation - immunology | Animals | B-Cell Activating Factor - metabolism | B-Cell Maturation Antigen - metabolism | B-Lymphocyte Subsets - metabolism | Autoimmunity - immunology | Immune Tolerance - immunology | B-Cell Activating Factor - immunology | B-Lymphocyte Subsets - immunology | Ligands | Toll-Like Receptors - metabolism | Transmembrane Activator and CAML Interactor Protein - immunology | Autoimmunity | Physiological aspects | B cells | Research | Tumor necrosis factor | Risk factors | Index Medicus
Journal Article
Seminars in immunology, ISSN 1044-5323, 2006, Volume 18, Issue 5, pp. 263 - 275
Signaling | BAFF | B cells | Structure | Splice variants | Life Sciences & Biomedicine | Immunology | Science & Technology | B-Cell Activating Factor - physiology | Alternative Splicing | Humans | Substrate Specificity | Structure-Activity Relationship | Lymphocyte Subsets - immunology | Immunoglobulin Class Switching - physiology | Protein Kinase C-delta - antagonists & inhibitors | B-Cell Activating Factor - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - chemistry | B-Cell Activation Factor Receptor - genetics | B-Cell Activation Factor Receptor - immunology | B-Cell Activation Factor Receptor - chemistry | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | B-Lymphocytes - cytology | Transmembrane Activator and CAML Interactor Protein - chemistry | Signal Transduction | B-Cell Maturation Antigen - physiology | Lymphocyte Activation | B-Cell Activating Factor - chemistry | Tumor Necrosis Factor Ligand Superfamily Member 13 - physiology | Models, Molecular | B-Cell Activation Factor Receptor - physiology | Transmembrane Activator and CAML Interactor Protein - physiology | Protein Interaction Mapping | Transmembrane Activator and CAML Interactor Protein - genetics | Animals | B-Lymphocytes - immunology | B-Cell Activating Factor - genetics | NF-kappa B - physiology | Protein Conformation | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Mice | NF-kappa B p50 Subunit - physiology | Apoptosis - physiology | Transmembrane Activator and CAML Interactor Protein - immunology | Antigen Presentation - physiology | Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 09/2015, Volume 192, Issue 6, pp. 695 - 705
Autoimmunity | Chronic obstructive pulmonary disease | B cell-activating factor of tumor necrosis factor family | Cigarette smoke | Lymphoid follicles | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Adaptive Immunity | Biomarkers - metabolism | Severity of Illness Index | Smoking - adverse effects | Smoking - immunology | Humans | Middle Aged | Bronchoalveolar Lavage Fluid - immunology | Male | Pulmonary Disease, Chronic Obstructive - pathology | Case-Control Studies | Disease Progression | Lymphoid Tissue - immunology | Lymphoid Tissue - pathology | B-Cell Activating Factor - metabolism | B-Lymphocytes - immunology | Adult | B-Cell Activating Factor - immunology | Female | Aged | Pulmonary Disease, Chronic Obstructive - metabolism | Pulmonary Disease, Chronic Obstructive - immunology | B-Lymphocytes - metabolism | Apoptosis | Index Medicus | Abridged Index Medicus | B cell–activating factor of tumor necrosis factor family | lymphoid follicles | autoimmunity | cigarette smoke | Original | chronic obstructive pulmonary disease
Journal Article
4.
Full Text
Signaling by the tumor necrosis factor receptor superfamily in B‐cell biology and disease
Immunological reviews, ISSN 0105-2896, 11/2011, Volume 244, Issue 1, pp. 115 - 133
BAFF | B cell | CD40 | BCMA | NF‐κB | TACI | NF-κB | Life Sciences & Biomedicine | Immunology | Science & Technology | Cell Proliferation | Humans | NF-kappa B - immunology | NF-kappa B - metabolism | Transmembrane Activator and CAML Interactor Protein - metabolism | Signal Transduction - immunology | CD40 Antigens - metabolism | B-Cell Activating Factor - immunology | B-Lymphocyte Subsets - immunology | CD40 Antigens - genetics | B-Cell Activation Factor Receptor - genetics | B-Lymphocytes - metabolism | B-Cell Activation Factor Receptor - immunology | B-Cell Maturation Antigen - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | Gene Expression | Mice, Transgenic | Cell Survival - immunology | Immunity, Innate | Tumor Necrosis Factor Ligand Superfamily Member 13 - metabolism | Transmembrane Activator and CAML Interactor Protein - genetics | B-Cell Activation Factor Receptor - metabolism | Animals | B-Cell Activating Factor - metabolism | B-Cell Maturation Antigen - metabolism | B-Lymphocytes - immunology | B-Lymphocyte Subsets - metabolism | NF-kappa B - genetics | B-Cell Activating Factor - genetics | Neoplasms - immunology | Autoimmune Diseases | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Mice | B-Cell Maturation Antigen - genetics | Transmembrane Activator and CAML Interactor Protein - immunology | CD40 Antigens - immunology | Autoimmunity | Antigens | Tumor necrosis factor | Tumors | Necrosis | Index Medicus
Journal Article
5.
Full Text
B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases
Digestive diseases and sciences, ISSN 0163-2116, 12/2016, Volume 61, Issue 12, pp. 3407 - 3424
Biochemistry, general | BAFF | Inflammatory bowel diseases | Medicine & Public Health | Hepatology | Gastroenterology | Oncology | B cells | Transplant Surgery | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Immunity, Humoral - immunology | Dendritic Cells - immunology | Humans | Immunosuppressive Agents - therapeutic use | Inflammatory Bowel Diseases - immunology | Recombinant Fusion Proteins - therapeutic use | Immunoglobulin Class Switching - immunology | Antibodies, Monoclonal - therapeutic use | Monocytes - immunology | Molecular Targeted Therapy | Th1 Cells - immunology | Rituximab - therapeutic use | B-Cell Activating Factor - antagonists & inhibitors | Immunoglobulin G - immunology | B-Cell Activating Factor - immunology | B-Cell Activation Factor Receptor - immunology | B-Cell Maturation Antigen - immunology | Inflammatory Bowel Diseases - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | B-Lymphocytes - immunology | Th17 Cells - immunology | T-Lymphocytes - immunology | Transmembrane Activator and CAML Interactor Protein - immunology | Immunologic Factors - therapeutic use | Plasma Cells - immunology | Medical colleges | Analysis | Immunoglobulin G | Monoclonal antibodies | Immunoglobulin A | T cells | Ulcerative colitis | Index Medicus | Abridged Index Medicus
Journal Article